|
HECA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.28840005120657E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.01250144221876E-11 |
| Normal-vs-Stage2 |
2.121800E-02 |
| Normal-vs-Stage3 |
1.785680E-04 |
| Normal-vs-Stage4 |
6.868200E-02 |
| Stage1-vs-Stage2 |
3.637800E-01 |
| Stage1-vs-Stage3 |
1.224420E-02 |
| Stage1-vs-Stage4 |
8.48589999999927E-05 |
| Stage2-vs-Stage3 |
7.206000E-01 |
| Stage2-vs-Stage4 |
2.100600E-01 |
| Stage3-vs-Stage4 |
1.136560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.39740005414779E-09 |
| Normal-vs-AfricanAmerican |
8.082600E-03 |
| Normal-vs-Asian |
1.529640E-01 |
| Caucasian-vs-AfricanAmerican |
5.940000E-01 |
| Caucasian-vs-Asian |
4.597400E-01 |
| AfricanAmerican-vs-Asian |
4.038800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10530000497056E-08 |
| Normal-vs-Female |
3.35910000037742E-07 |
| Male-vs-Female |
8.671400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.816180E-02 |
| Normal-vs-Age(41-60Yrs) |
2.78570000400435E-09 |
| Normal-vs-Age(61-80Yrs) |
3.3863999999717E-06 |
| Normal-vs-Age(81-100Yrs) |
3.479800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.163000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.310000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.117200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.153800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.218000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.348400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.640700E-04 |
| Normal-vs-Grade 2 |
3.49360540496946E-11 |
| Normal-vs-Grade 3 |
4.350300E-04 |
| Normal-vs-Grade 4 |
2.103700E-02 |
| Grade 1-vs-Grade 2 |
1.363210E-01 |
| Grade 1-vs-Grade 3 |
1.619020E-04 |
| Grade 1-vs-Grade 4 |
1.579160E-03 |
| Grade 2-vs-Grade 3 |
5.77529999999937E-05 |
| Grade 2-vs-Grade 4 |
2.000700E-03 |
| Grade 3-vs-Grade 4 |
8.315400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.49990078322094E-11 |
| Normal-vs-ccB subtype |
1.63770999999091E-05 |
| ccA subtype-vs-ccB subtype |
3.497600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74279999987093E-07 |
| Normal-vs-N1 |
4.289600E-01 |
| N0-vs-N1 |
2.819800E-01 |
|
|
